110 related articles for article (PubMed ID: 16763572)
1. Monoclonals expand into neural disorders.
Vastag B
Nat Biotechnol; 2006 Jun; 24(6):595-6. PubMed ID: 16763572
[No Abstract] [Full Text] [Related]
2. Next-generation monoclonals less profitable than trailblazers?
Mitchell P
Nat Biotechnol; 2005 Aug; 23(8):906. PubMed ID: 16082347
[No Abstract] [Full Text] [Related]
3. [Therapeutic monoclonal antibodies: knowledge transfer from Inserm].
Perrin-Wolff M; Cans C
Med Sci (Paris); 2009 Dec; 25(12):1193-5. PubMed ID: 20035705
[No Abstract] [Full Text] [Related]
4. [Therapeutic monoclonal antibodies in the French community: let's get organized].
Watiez D; Watier H
Med Sci (Paris); 2009 Dec; 25(12):1189-92. PubMed ID: 20035704
[No Abstract] [Full Text] [Related]
5. Just mad about mAbs.
Jacobs T
Nat Biotechnol; 2002 Sep; 20(9):869. PubMed ID: 12205498
[No Abstract] [Full Text] [Related]
6. A very firm handshake: biotech's growing negotiating power.
Thiel KA
Nat Biotechnol; 2005 Oct; 23(10):1221-6. PubMed ID: 16211058
[No Abstract] [Full Text] [Related]
7. Pfizer jettisons Esperion.
Shaffer C
Nat Biotechnol; 2008 Jul; 26(7):724-5. PubMed ID: 18612282
[No Abstract] [Full Text] [Related]
8. Can 'double blockbuster' strengthen Amgen's backbone?
Sheridan C
Nat Biotechnol; 2008 Apr; 26(4):361-3. PubMed ID: 18391999
[No Abstract] [Full Text] [Related]
9. Tysabri back on market.
Sheridan C
Nat Biotechnol; 2006 Aug; 24(8):874. PubMed ID: 16900111
[No Abstract] [Full Text] [Related]
10. Advice for partnering with pharma.
Howard K
Nat Biotechnol; 2004 Nov; 22(11):1477-9. PubMed ID: 15586421
[No Abstract] [Full Text] [Related]
11. GSK moves on Sirtris.
Sipp D
Nat Biotechnol; 2008 Jun; 26(6):595. PubMed ID: 18536662
[No Abstract] [Full Text] [Related]
12. Amgen becomes a stronger cancer player.
Kling J
Nat Biotechnol; 2006 Feb; 24(2):119. PubMed ID: 16465140
[No Abstract] [Full Text] [Related]
13. Exiting this year and into the next.
Nat Biotechnol; 2005 Dec; 23(12):1451. PubMed ID: 16333272
[No Abstract] [Full Text] [Related]
14. Merv Turner.
Turner M
Nat Biotechnol; 2011 Mar; 29(3):186. PubMed ID: 21390005
[No Abstract] [Full Text] [Related]
15. Nurse Practitioner Corporate Partner Council.
Dempster JS
J Am Acad Nurse Pract; 2007 Jan; 19(1):49. PubMed ID: 17214868
[No Abstract] [Full Text] [Related]
16. Nurse Practitioner Corporate Partner Council.
Dempster JS
J Am Acad Nurse Pract; 2007 Dec; 19(12):676-7. PubMed ID: 18042133
[No Abstract] [Full Text] [Related]
17. Millennium ends Takeda's US shopping spree.
Sipp D
Nat Biotechnol; 2008 Jun; 26(6):593-5. PubMed ID: 18536661
[No Abstract] [Full Text] [Related]
18. Genomics companies shop around for chemical expertise.
Fletcher L
Nat Biotechnol; 2004 Feb; 22(2):137-8. PubMed ID: 14755277
[No Abstract] [Full Text] [Related]
19. A reprise for collaborative financing in biotech.
Ransom J
Nat Biotechnol; 2006 Aug; 24(8):873-4. PubMed ID: 16900110
[No Abstract] [Full Text] [Related]
20. Antiinfective biotechs face partnering gap.
Sheridan C
Nat Biotechnol; 2005 Feb; 23(2):155-6. PubMed ID: 15696131
[No Abstract] [Full Text] [Related]
[Next] [New Search]
